Article Details
Retrieved on: 2024-11-04 17:34:02
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights HiFiBiO Therapeutics' FDA clearance for its monoclonal antibody, HFB200604, a BTLA agonist targeting autoimmune diseases. This relates to biotech by demonstrating advances in immunotherapy and antibody development.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here